Delivery Order SPE2DX15D1053-SPE2DX23F6LUA
- Not listed
- This is a delivery order under a larger indefinite delivery contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The order is for the supply of 4565615949 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a prescription medication, at a ceiling value of $1,043.43. The delivery order has a firm fixed price and an ultimate completion date of August 29, 2024. This contract does not have a set-aside...
- This federal contract award, valued at $2,326.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4560052860 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product, with a completion date of February 27, 2023. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of 4563361151 FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product, with a potential value of $2,564.88. The contract has a completion date of January 22, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a range of pharmaceutical products and medical supplies to support...
- This federal contract award, valued at $2,565.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4559786379 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 300ML, a pharmaceutical product, with a completion date of February 1, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award is for the delivery order SPE2DB24FNPA6 placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 4564702458 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 150ML, a pharmaceutical product, with a ceiling value of $1,042.56. The contract is a firm fixed price delivery order with an ultimate completion date of May 24, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award with the Defense Logistics Agency (DLA) Troop Support Medical was made to Amerisourcebergen Drug Corp, one of the largest pharmaceutical distributors in the U.S. The $1,554.28 firm-fixed-price delivery order is for the supply of 4565927278 OMEPRAZOLE DR 40 MG CAPSULE 500S. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Omeprazole 2 mg/mL suspension in 300 mL bottles, with a ceiling value of $2,380.39 and a completion date of September 20, 2024. The contract is a firm-fixed price, delivery order type, with no set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded numerous...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the delivery of pharmaceutical products, specifically Omeprazole DR 40 mg capsules. The contract has a ceiling value of $1,261.69 and an ultimate completion date of September 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the...
- The Defense Logistics Agency awarded a delivery order valued at $1,560.42 to AmerisourceBergen Drug Corp for the supply of Omeprazole DR 40 mg capsules (500 count) under a firm fixed-price contract. This non-set-aside award, issued on November 6, 2025, with an ultimate completion date of November 7, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Omeprazole DR 20 mg capsules (1,000 count) at a firm fixed price of $1,468.32, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of...
- SPE2DX15D1053Indefinite Delivery Contract
- SPE2DX15D1053-SPE2DX23F6LUADelivery Order
This is a $1,885.88 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The award is for the supply of 4560633797 - FIRST-OMEPRAZOLE 2 MG/ML SUSP 90ML, with an ultimate completion date of April 19, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 4/18/23 |